# Galia Gestion

> Galia Gestion is a VC fund in Bordeaux backing Software and Manufacturing. See 55 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Bordeaux, France
- Total investments: 55
- Last investment: Jan 2023
- Lead investor: 24%
- Fund size: $21M
- Last fund: Jul 2013
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/galia-gestion/
- Website: http://www.galia-gestion.com

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

## Contacts

5 contacts available for Galia Gestion. Shizune tracks 7 team members at Galia Gestion. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/galia-gestion?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $531k–$2.9M |
| Series A | $849k–$6.9M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 12 | 22% |
| Manufacturing | 11 | 20% |
| Biotechnology | 7 | 13% |
| Industrial | 6 | 11% |
| Health Care | 5 | 9% |

76 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 25 | 45% |
| Series A | 12 | 22% |
| Seed | 7 | 13% |
| Series B | 5 | 9% |
| Venture - Series Unknown | 4 | 7% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 48 | 87% |
| United States | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Christian Joubert | General Manager, President and CEO | 0 | https://shizune.co/investors/profile/christian-joubert |
| Christophe DOUFFET | Investment Director and Partner | 0 | https://shizune.co/investors/profile/christophe-douffet |
| Claudia Daugan | Senior Business Officer | 1 | https://shizune.co/investors/profile/claudia-daugan |
| Roman Compiegne | Chargé d'Affaires | 0 | https://shizune.co/investors/profile/roman-compiegne |
| Véronique Bernard | Secretary General | 0 | https://shizune.co/investors/profile/vronique-bernard |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Agenium | Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors. | $2.4M | Venture - Series Unknown | Jan 19, 2023 |  |
| Wizaly | Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations. | $6M | Venture - Series Unknown | Sep 15, 2022 |  |
| Germitec SAS | Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system. | $11.6M | Venture - Series Unknown | May 10, 2022 |  |
| Mon Chasseur Immo | Mon Chasseur Immo is a Real Estate, based in Languedoc Roussillon. | $10.5M | Venture - Series Unknown | May 10, 2022 |  |
| Terakalis | Terakalis is the result of a technological partnership started in 2012 with the Charles Coulomb laboratory (L2C), a mixed CNRS-University of Montpellier unit. The field of TeraHertz electromagnetic waves (100 Ghz-10THz) is at the heart of this collaboration. | $3.2M | Series A | Mar 18, 2022 |  |
| FineHeart | The company intends to use the funds to finance the development of its first product.France-based medical device company focused on innovative technologies in the cardiovascular space | $25.7M | Series B | Jun 01, 2021 |  |
| TreeFrog Therapeutics | TreeFrog Therapeutics is a developer of stem cells intended to secure cell production and quality, fasten clinical development and facilitate market access. The company's offerings include a proprietary technology platform that provides an end to end 3D scalable solution that will dramatically reduce treatment costs, enabling patients toaccess the medical revolution of cell therapies by overcoming current critical manufacturing issues. | $6.9M | Series A | May 13, 2019 |  |
| My-Serious-Game | As the French leader in customized digital training, My-Serious-Game develops the knowledge of your employees, enhances their soft skills and mobilizes them, through tailor-made gamified solutions such as 3D simulations, competitive mobile challenges, blended learning or VR.Dare to learn in a fun and technological way! Catch and keep thetrainees’ attention by offering them real immersive adventures. Combining techno-pedagogy, storytelling, technologies and techniques borrowed from the world of video games, they plunge your learners into a new formative, powerful and engaging experience. | $3.3M | Series A | Jan 14, 2019 |  |
| Loisirs Enchères | Loisirs Enchères is a auction site for holidays and leisure activities. | $4.4M |  | Nov 26, 2018 |  |
| Antabio | Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need. It develops stand-alone inhibitors of bacterial metalloenzymes that can be combined with various antibiotics to restore their activity against the most critical pathogens. Thecompany's novel inhibitor of bacterial Metallo ß-lactamases (“MBLs”) which will be combined with a carbapenem to fill an important gap in the treatment of drug-resistant infections. They develop a novel, safe and efficacious inhibitor of bacterial Metallo ß-lactamases to be combined with a carbapenem for the treatment of drug-resistant nosocomial infections.Antabio received a Wellcome Trust Seeding Drug Discovery Award. The company was founded in 2009 and is headquartered in Labege, France. | $5.7M | Series A | Jul 12, 2018 |  |

10 of 55 investments shown.

## Co-investors
- [AQUITI Gestion](https://shizune.co/investors/profile/aquiti-gestion-aci) — VC Fund, 15 deals together
- [IRDI](https://shizune.co/investors/profile/irdi-midi-pyrenees) — VC Fund, 10 deals together
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 5 deals together
- [IRDI-ICSO](https://shizune.co/investors/profile/irdi-icso) — VC Fund, 3 deals together
- [M Capital Partners](https://shizune.co/investors/profile/m-capital-partners) — VC Fund, 3 deals together
- [Auriga Partners](https://shizune.co/investors/profile/auriga-partners) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [All Investors in France](https://shizune.co/investors/investors-france)
- [All VC Funds in France](https://shizune.co/investors/vc-funds-france)
- [Climate Investors in France](https://shizune.co/investors/climate-investors-france)
- [Climate VC Funds in France](https://shizune.co/investors/climate-vc-funds-france)
- [Manufacturing Investors in Europe](https://shizune.co/investors/manufacturing-investors-europe)
- [Manufacturing VC Funds in Europe](https://shizune.co/investors/manufacturing-vc-funds-europe)

## FAQ

### What does Galia Gestion invest in?

Galia Gestion invests primarily in Software, Manufacturing and Biotechnology startups, most often at Funding Round and Series A stage. Most of the 55 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Galia Gestion's check size?

Galia Gestion typically joins rounds of $531k–$2.9M at Seed and $849k–$6.9M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Galia Gestion participates in.

### How do I contact Galia Gestion?

Public channels for Galia Gestion include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Galia Gestion?

The team at Galia Gestion includes Christian Joubert (General Manager, President and CEO), Christophe DOUFFET (Investment Director and Partner) and Claudia Daugan (Senior Business Officer), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co